The published data demonstrated that InsP5 inhibited AKT phosphorylation and activity and promoted apoptosis via PI3K/AKT pathway in small cell lung cancer (SCLC-H69), ovarian cancer (SKOV3) and breast cancer (SKBR-3) cell lines [53]. This evidence concerns the gene AKT1 and ovarian cancer.